Please login to the form below

Not currently logged in

Excellence in Patient Education and Support

Back to categories

Judging criteria:

Evidence of deep market and customer insight (10)

  • Demonstrate how you gained deep and meaningful insights into patient needs.

Clarity and appropriateness of objectives (10)

  • Demonstrate how your objectives related to all stakeholders and reinforced each other.
  • The rigour and ambition of your objective-setting.

Quality of strategy development based on insights (15)

  • Demonstrate how you aimed to address patient needs in your strategy
  • Demonstrate what specific insights led to your choice of particular strategy

Quality of execution (10)

  • Evidence of differentiated content being provided in a meaningful way to customers either through an integrated multichannel programme or carefully selected channels
  • Evidence of differentiation and enhanced value for the patient.

Quality of measurement and learning (10)

  • Demonstrate how metrics have been applied to measure outcomes, take further action and enable learning
  • Demonstrate how data captured is being leveraged and used to adapt strategy and tactics on an ongoing basis.

Quality of changed perceptions and behaviours that will deliver improved health outcomes (15)

  • Measure of change in patient outcomes and direct patient feedback
  • Evidence of customer engagement and positive supportive statements from patients (and, where appropriate, HCPs).

This award highlights the importance of the patient within today’s healthcare environment.

It recognises work that has made a significant and measurable difference to a specific group of patients to support understanding and management of their condition. It can include the creation of new patient insights, orientation of a team around the patient and delivery of consistent quality patient experiences through the interactions, tools and services from the team.

Eligible initiatives will have modified the perception and/or behaviour of patients to contribute to the achievement of one or more of the following:

  • Improved understanding of the condition and its treatment
  • Improved self-management or monitoring
  • Improved adherence
  • Improved access to treatment.

Potential entrants might include:

  • Charities
  • Patient or professional associations/bodies
  • Providers of healthcare services around the world (such as the NHS/Department of Health in the UK)
  • Pharmaceutical company teams
  • Healthcare agencies/consultancies.

Work conducted during the two-year period between July 2017 and June 2019 will be eligible.


Back to categories


Key dates

Entry deadline 29 August 2019
Extended entry deadline 5 September 2019*
*additional fee applies
Judging day 26 September 2019
Company/Team Interviews 9 October 2019
PMEA Event 27 November 2019